The study, published in Lancet Oncology on Oct. 25, gave 50 women chemotherapy and measured the recurrence rates of their tumors. Thirty-one participants responded well and no longer needed surgery after the treatment.
Participants then went under radiation treatment. After more than two years, these 31 patients were still in remission.
Eliminating surgery for invasive breast cancer is “the ultimate form of breast-conserving therapy,” Henry Kuerer, MD, principal investigator told the New York Times.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
